Rigel Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RIGL and other ETFs, options, and stocks.

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

CEO

Raul R. Rodriguez

CEORaul R. Rodriguez

Employees

164

Employees164

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1996

Founded1996

Employees

164

Employees164

RIGL Key Statistics

Market cap

353.34M

Market cap353.34M

Price-Earnings ratio

8.82

Price-Earnings ratio8.82

Dividend yield

—

Dividend yield—

Average volume

268.55K

Average volume268.55K

High today

$20.11

High today$20.11

Low today

$18.13

Low today$18.13

Open price

$18.43

Open price$18.43

Volume

240.56K

Volume240.56K

52 Week high

$29.82

52 Week high$29.82

52 Week low

$7.48

52 Week low$7.48

Analyst ratings

67%

of 6 ratings

Buy

33.3%

Hold

66.7%

Sell

People also own

Based on the portfolios of people who own RIGL. This list is generated using Robinhood data, and it’s not a recommendation.